Table 2. Treatment Parameters and Outcomes.

Variable	TN1 Cases (n = 125)	TN2 Cases (n = 38)
Median Prescription Dose (Gy) (range)	60.00 (49.00 - 75.00)	73.50 (47.78 - 75.00)
Median Dmax (Gy) (range)	75.00 (67.42 - 110.29)	75.00 (70.00 - 78.48)
Median Isodose (range)	80% (55% - 100%)	100% (68.3% - 100%)
Median Time to Follow-up (range)	4 months (0.25 - 44 months)	5 months (0.25 - 41 months)
Mean pre-treatment VAS score (95% CI)	7.47 (7.00 - 7.94)	6.89 (5.93 - 7.86)
Mean post-treatment VAS score (95% CI)	1.86 (1.33 - 2.38)	1.84 (0.82 - 2.87)
Mean VAS score decline (95% CI)	5.62 (4.93 - 6.32)	5.05 (3.82 - 6.29)
Patients with declines in VAS scores	87.2%	86.8%
Patients with no change in VAS scores	5.6%	7.9%
Patients with increases in VAS scores	7.2%	5.3%